These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2272726)

  • 1. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.
    Suzuki M; Higuchi S; Taki Y; Taki S; Miwa K; Hamuro J
    Int J Immunopharmacol; 1990; 12(6):613-23. PubMed ID: 2272726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.
    Kawase I; Komuta K; Shirasaka T; Hara H; Tanio Y; Watanabe M; Saito S; Ikeda T; Masuno T; Kishimoto S
    Jpn J Cancer Res; 1989 Nov; 80(11):1089-97. PubMed ID: 2514171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
    Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells.
    Kawase I; Shirasaka T; Ikeda T; Hara H; Tanio Y; Watanabe M; Saito S; Masuno T; Kishimoto S; Yamamura Y
    Jpn J Cancer Res; 1989 Nov; 80(11):1098-105. PubMed ID: 2481664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.
    Suzuki M; Kikuchi T; Takatsuki F; Hamuro J
    Cancer Immunol Immunother; 1994 Jan; 38(1):1-8. PubMed ID: 8299113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP; Manning LS; Robinson BW
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
    Thompson RA; Ballas ZK
    J Immunol; 1990 Nov; 145(10):3524-31. PubMed ID: 1700014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
    Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
    Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde.
    Kuroki Y; Ochiai H; Kurokawa M; Niwayama S; Kishimoto C; Tazawa K; Fujimaki M
    J Cancer Res Clin Oncol; 1991; 117(2):109-14. PubMed ID: 2007609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
    Lin TH; Chu TM
    Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro.
    Helfand SC; Soergel SA; Modiano JF; Hank JA; Sondel PM
    Cancer Biother; 1994; 9(3):237-44. PubMed ID: 7820185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level.
    Chikkala NF; Lewis I; Ulchaker J; Stanley J; Tubbs R; Finke JH
    Cancer Res; 1990 Feb; 50(4):1176-82. PubMed ID: 2297766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS; Suzuki H; Yano S
    Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of basic procedures for adoptive immunotherapy for gastric cancer.
    Fujimoto T; Omote K; Mai M; Natsuume-Sakai S
    Biotherapy; 1992; 5(2):153-63. PubMed ID: 1524956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice.
    Ohnishi H; Lin KM; Chu TM
    Cancer Res; 1990 Feb; 50(4):1107-12. PubMed ID: 2297759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro].
    Li JF; Guo JW; Huang XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Apr; 16(4):224-6. PubMed ID: 9206247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
    Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of lymphokine activated killer (LAK) and prolongation of its activity by intrasplenic injection of interleukin 2 (IL-2) in combination with tumor necrosis factor (TNF)].
    Nakajima I; Okuno K; Ohnishi H; Shilayama Y; Nakamura T; Hirohata T; Yasutomi M
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1548-53. PubMed ID: 2263237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.